Stratification of Patients With Interstitial Cystitis/Bladder Pain Syndrome According to the Anatomical Bladder Capacity.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
01 2019
Historique:
received: 24 05 2018
revised: 04 07 2018
accepted: 23 07 2018
pubmed: 1 9 2018
medline: 16 5 2019
entrez: 1 9 2018
Statut: ppublish

Résumé

To compare the data of score symptoms (Interstitial Cystitis Problem Index, Interstitial Cystitis Symptom Index, Pelvic Pain and Urgency/Frequency Patient Symptom Scale and SF-36quality of life), voiding diaries, urodynamic studies, and cystoscopy under general anesthesia according to the anatomical bladder capacity for patients with interstitial cystitis/bladder pain syndrome (IC/BPS). Single-centre descriptive observational epidemiological study based on retrospective review of 134 patients managed for IC/BPS between January 2010 and December 2016. Patients were stratified into 2 groups according to anatomical bladder capacity measured under general anesthesia: ≤400 mL (n = 40) and >400 mL (n = 94). Patients with an anatomical bladder capacity less than 400 of mL presented significantly different results for voiding diary data: higher total frequency (P = .0023) especially at night (P = .0008), lower functional bladder capacity (P = .0082) and lower maximum bladder capacity (P = .0001); urodynamic data: earlier onset of painful urge during bladder filling (P = .0002), lower maximum bladder filling capacity (P = .0001) and lower compliance (P = .0067); and the findings of cystoscopy under general anesthesia: more Hunner's lesions (P = .00013). These patients presented poorer Pelvic Pain and Urgency/Frequency Patient Symptom Scale symptom scores (P = .0176) but associated with better overall quality of life as assessed by SF-36 (P = .0295). The anatomical bladder capacity, measured under general anesthesia, can be used objectively to define 2 distinct groups of patients with symptoms of IC/BPS.

Identifiants

pubmed: 30170094
pii: S0090-4295(18)30900-2
doi: 10.1016/j.urology.2018.07.046
pii:
doi:

Types de publication

Comparative Study Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

87-92

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Charles Mazeaud (C)

Department of Urology, Nantes University Hospital, Nantes, France.

Jérôme Rigaud (J)

Department of Urology, Nantes University Hospital, Nantes, France. Electronic address: jrigaud@chu-nantes.fr.

Amélie Levesque (A)

Department of Urology, Nantes University Hospital, Nantes, France.

François-Xavier Madec (FX)

Department of Urology, Nantes University Hospital, Nantes, France.

Quentin-Come Le Clerc (QC)

Department of Urology, Nantes University Hospital, Nantes, France.

Maxime Wack (M)

Department of Epidemiology and Biostatistics, Nancy University Hospital, Nancy Cedex, France.

Loïc Le Normand (L)

Department of Urology, Nantes University Hospital, Nantes, France.

Thibault Riant (T)

Pain Unit, Le Confluent, Catherine de Sienne Center, Nantes, France.

Marie-Aimée Perrouin-Verbe (MA)

Department of Urology, Nantes University Hospital, Nantes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH